Spontaneous and Evoked Measures of Pain in Murine Models of Monoarticular Knee Pain
February 22nd, 2019
8.6K views
We have developed an evoked measure of arthritis pain and coupled it with a standardized method for measuring spontaneous pain in different murine models of chemically induced arthritis. These measures are sensitive and reproducible for different types of joint pain.
Overview
This study presents a sensitive and reproducible protocol for measuring both evoked and spontaneous pain in murine models of chemically induced arthritis. The methodology is crucial for evaluating treatments for arthritis, which is a leading cause of disability.
Key Study Components
Area of Science
- Neuroscience
- Pain Measurement
- Arthritis Research
Background
- Arthritis is a major contributor to disability, with pain being a significant factor.
- Current treatments for arthritis are inadequate, necessitating better pre-clinical models.
- Measuring pain in these models is essential for developing effective therapies.
- This study aims to improve pain assessment methodologies in murine models.
Purpose of Study
- To develop a reliable method for assessing evoked and spontaneous pain in arthritis models.
- To facilitate the evaluation of regenerative and analgesic treatments.
- To provide a standardized approach for future research in arthritis pain measurement.
Methods Used
- Use of a sheathed needle for joint injections in anesthetized mice.
- Application of consistent pressure to assess evoked pain responses.
- Utilization of advanced dynamic weight bearing software for measuring spontaneous pain behaviors.
- Recording and analyzing vocalizations and escape attempts as indicators of pain.
Main Results
- Evoked Pain Scores increased in various arthritis models compared to naive mice.
- Differences in weight bearing were observed between male and female mice with chronic degenerative joint pain.
- Females with chronic pain showed more time on the non-arthritic limb compared to naive mice.
- The methodology effectively distinguishes between different types of joint pain in mice.
Conclusions
- The developed protocol is a valuable tool for assessing pain in arthritis research.
- It allows for the evaluation of new analgesics and treatment strategies.
- Further studies can build on this methodology to enhance arthritis treatment development.
Frequently Asked Questions
What is the significance of measuring pain in arthritis models?
Measuring pain is crucial for evaluating the effectiveness of potential treatments for arthritis, which is a major cause of disability.
How does the protocol improve pain assessment?
The protocol is sensitive and reproducible, allowing for accurate measurement of both evoked and spontaneous pain behaviors.
What are the main components of the pain measurement protocol?
The protocol includes joint injections, pressure application, and the use of advanced software for data analysis.
Can this method be applied to other pain models?
Yes, the methodology can be adapted for various pre-clinical pain models beyond arthritis.
What are the implications of the study's findings?
The findings highlight the need for improved pain measurement techniques, which can lead to better treatment options for arthritis patients.
Who conducted the study?
The study was conducted by Christopher Dorman and Sandra Frizelle from the research laboratory.
Executive Industry Relevance
Quantitative assessment of pain in murine monoarticular knee models addresses a critical gap in preclinical arthritis research, enabling robust evaluation of both disease-modifying and analgesic candidates. These reproducible measures of evoked and spontaneous pain support predictive confidence in translational pain endpoints and facilitate risk-adjusted advancement of novel therapeutics. Standardized pain phenotyping at this stage enhances portfolio triage and informs go/no-go decisions for arthritis drug development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of pain mechanisms and functional target validation in arthritis models.
- Supports biological de-risking by distinguishing between inflammatory and degenerative pain phenotypes.
- Provides quantitative endpoints for hypothesis-driven evaluation of candidate interventions.
Screening & Assay Development
- Establishes validated, reproducible pain assays for compound screening in murine models.
- Facilitates standardization of evoked and spontaneous pain measurements across studies.
- Generates quantitative outputs suitable for cross-comparison of analgesic and disease-modifying agents.
Translational & Preclinical Research
- Aligns preclinical pain endpoints with clinically relevant functional outcomes.
- Enables continuity from discovery through preclinical validation of arthritis therapeutics.
- Supports risk-adjusted advancement decisions based on robust pain phenotyping.
Pipeline & Workflow Integration
These pain measurement protocols integrate into the discovery-to-preclinical continuum, providing standardized endpoints for both early target validation and late-stage efficacy studies.
- Discovery Biology: Quantitative pain scoring supports mechanistic hypothesis testing and pathway clarification in arthritis models.
- Screening: Assay reproducibility and sensitivity enable reliable evaluation of candidate compounds.
- Analytics: Automated software outputs facilitate objective comparison of pain responses across experimental groups.
- Translational Research: Functional pain measures bridge preclinical findings to clinical pain endpoints.
- Enterprise Reuse: Protocols are adaptable for diverse arthritis models and analgesic screening campaigns.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in pain research.
- Operational Value: Delivers standardized, scalable, and reproducible pain assessment workflows.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency in arthritis portfolios.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of pain-modifying therapeutics.
Implementation Considerations
- Requires expertise in murine handling and pain behavior assessment.
- Needs access to calibrated force application devices and dynamic weight bearing software.
- Demands cross-team standardization of scoring and data analysis protocols.
- Adaptable to various arthritis models but may require protocol optimization for specific phenotypes.
- Dependent on accurate limb identification and consistent experimental conditions.
Biopharma FAQs
Why does null hypothesis testing matter for evoked pain scoring?
Null hypothesis testing in evoked pain scoring enables objective determination of whether observed pain responses differ significantly between treatment and control groups, supporting robust target validation and mechanistic de-risking in arthritis models.
How does independent variable isolation fit dynamic weight bearing analysis?
Isolating the independent variable, such as the injected substance, ensures that changes in dynamic weight bearing are attributable to the intervention, strengthening the predictive value of pain phenotyping in the discovery pipeline.
What do quantitative dependent variable measurements enable in arthritis models?
Quantitative measurements of vocalizations, escape attempts, and limb weight distribution provide reproducible endpoints for comparing analgesic efficacy and disease-modifying effects across candidate compounds.
Why are replication requirements critical for cross-functional pain studies?
Replication ensures that pain assessment results are consistent and reliable across different operators and experimental runs, facilitating cross-functional collaboration and data integration in multi-site R&D programs.
What statistical analysis capabilities are required before implementing pain scoring protocols?
Robust statistical analysis, including group comparisons and variance assessment, is essential to validate pain scoring outputs and support data-driven advancement decisions in preclinical arthritis research.
